Organogenesis Holdings Inc.
NASDAQ:ORGO
3.19 (USD) • At close December 27, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Organogenesis Holdings Inc. |
Symbool | ORGO |
Munteenheid | USD |
Prijs | 3.19 |
Beurswaarde | 401,065,940 |
Dividendpercentage | 0% |
52-weken bereik | 2.165 - 4.705 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Gary S. Gillheeney Sr. |
Website | https://organogenesis.com |
An error occurred while fetching data.
Over Organogenesis Holdings Inc.
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)